Mumps vaccine: New study finds no harm in new drug

A study has found that the MMR vaccine does not have any harmful side effects, according to a new report by the World Health Organization. 

The WHO said in a press release Wednesday that a study published in the Journal of the National Cancer Institute (JNCI) found no evidence that the vaccine causes any type of cancer or other serious side effects. 

WHO has previously said that the new study found no harm from the vaccine. 

“The vaccine has been used in more than half the world and is generally well tolerated, safe and effective, said Dr. Rama Rajagopalan, director of the WHO’s Vaccine and Immunization Program in Geneva, Switzerland. 

Rajagopan is also the director of global vaccine safety and efficacy at the University of Maryland, Baltimore County. 

In its statement, WHO said that since the vaccine is currently available in only a handful of countries and has only been licensed for one country since 1996, the findings are a milestone for the vaccine and a reminder that the health risks of MMR vaccination are well understood. 

Dr. Robert W. Thompson, a WHO expert in infectious diseases, said that while there was no evidence of an increased risk of adverse effects in people who received the vaccine in the United States, he added that there is a concern that the number of people who have received the MMR vaccination in the U.S. could be significantly lower. 

Waters said he was hopeful that the WHO would consider recommending the vaccine as a preventive measure, given that it is used in only about half the countries in the world. 

If the WHO recommends the vaccine, it would mark the first time the vaccine has gone on the market. 

It is estimated that there are about 13 million cases of measles and about 1.2 million cases that are associated with the MMR vaccines. 

According to the CDC, the average age of a person vaccinated is 15 years old. 

Although the WHO has said that MMR vaccination has not caused any new cases of the disease, there have been concerns that some of the vaccine recipients in the study had high levels of the virus. 

Last year, the vaccine was recalled in the Netherlands, where more than 5,000 cases of pneumonia and fever were linked to the vaccine’s use.